Andrea Pace

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 386 citations

Medicine, Oncology, Pharmacology +13

Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy

Andrea Pace, Antonella Savarese, Mauro Picardo et al. · Journal of Clinical Oncology · 2003 · 311 citations

Medicine, Oncology, Pharmacology +13

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

Andrea Pace, Antonello Vidiri, Edvina Galiè et al. · Annals of Oncology · 2003 · 262 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity Scale

Guido Cavaletti, Barbara Frigeni, Francesca Lanzani et al. · Journal of the Peripheral Nervous System · 2007 · 251 citations

Medicine, Neurology, Oncology +17

Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire

Marieke van Leeuwen, Olga Husson, Paola Alberti et al. · Health and Quality of Life Outcomes · 2018 · 236 citations · Full text

Pharmacy, Oncology, Cancer Survivorship Care +16